Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies

Stock Information for Avant Technologies Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Avant Technologies Inc

From Diagnosis to Surgery: How AI Tech Is Quietly Reshaping Healthcare Profits
Avant Technologies' Joint Venture Partner Presents AI Technology at Roche Ophthalmology Conference
Avant Technologies and JV Partner, Ainnova, Complete Pivotal Meeting with U.S. FDA
Healthcare's $110B AI Surge Is Picking Up Speed--and It's Just the Beginning
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America
Doctors Are Being Outpaced by AI-Powered Algorithms -- Here's What It Means for Investors
AI Is Quietly Reinventing Healthcare--And Real Deployments Are Now Underway
Avant Technologies and JV Partner, Ainnova, Prepare for Key FDA Milestone with Next Week's Pre-Submission Meeting

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.